Alyeska Investment Group
LLY icon

Alyeska Investment Group’s Eli Lilly LLY Stock Holding History

Alyeska Investment Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688K Buy
+574
New +$586K ﹤0.01% 616
2026
Q1 		– Sell
-522
Closed -$561K – 692
2025
Q4 		$561K Buy
+522
New +$499K ﹤0.01% 556
2025
Q2 		– Sell
-3,055
Closed -$2.52M – 625
2025
Q1 		$2.52M Buy
+3,055
New +$2.54M 0.01% 407
2024
Q3 		– Sell
-82,078
Closed -$74.3M – 626
2024
Q2 		$74.3M Sell
82,078
-78,266
-49% -$62.6M 0.42% 76
2024
Q1 		$125M Sell
160,344
-30,738
-16% -$21.9M 0.77% 28
2023
Q4 		$111M Buy
191,082
+34,243
+22% +$20M 0.74% 29
2023
Q3 		$84.2M Buy
+156,839
New +$80.8M 0.57% 48
2022
Q4 		– Sell
-261,724
Closed -$84.6M – 468
2022
Q3 		$84.6M Buy
+261,724
New +$82.9M 0.99% 14
2022
Q1 		– Sell
-3,077
Closed -$850K – 629
2021
Q4 		$850K Sell
3,077
-215,222
-99% -$54.6M 0.01% 543
2021
Q3 		$50.4M Buy
218,299
+60,362
+38% +$14.9M 0.62% 32
2021
Q2 		$36.3M Sell
157,937
-207
-0.1% -$41.6K 0.42% 66
2021
Q1 		$29.5M Sell
158,144
-75,983
-32% -$14.9M 0.38% 71
2020
Q4 		$39.5M Buy
234,127
+21,901
+10% +$3.27M 0.56% 45
2020
Q3 		$31.4M Buy
+212,226
New +$32.8M 0.48% 56
2017
Q2 		– Sell
-1,580,087
Closed -$133M – 510
2017
Q1 		$133M Buy
1,580,087
+272,923
+21% +$21.9M 1.08% 9
2016
Q4 		$96.1M Buy
1,307,164
+844,505
+183% +$62.9M 0.8% 19
2016
Q3 		$37.1M Buy
+462,659
New +$37M 0.34% 94
2015
Q4 		– Sell
-39,604
Closed -$3.31M – 428
2015
Q3 		$3.31M Buy
+39,604
New +$3.34M 0.04% 294
2015
Q2 		– Sell
-601,652
Closed -$43.7M – 536
2015
Q1 		$43.7M Buy
601,652
+142,491
+31% +$10.1M 0.61% 28
2014
Q4 		$31.7M Sell
459,161
-16,444
-3% -$1.11M 0.54% 52
2014
Q3 		$30.8M Sell
475,605
-22,493
-5% -$1.42M 0.63% 34
2014
Q2 		$31M Buy
+498,098
New +$29.7M 0.69% 23

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alyeska Investment Group's LLY Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Eli Lilly (LLY) in Q2 2026: 574 shares worth $688K. The stake represents ﹤0.01% of the portfolio and ranks #616 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in LLY as recently as Q4 2025.

Alyeska Investment Group first reported a position in LLY in Q2 2014 and has held it in 22 quarters since. The position peaked at $133M in Q1 2017. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alyeska Investment Group held 574 shares of Eli Lilly worth $688K as of Q2 2026.
  • Eli Lilly was a new Alyeska Investment Group position in Q2 2026.
  • Eli Lilly made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #616 holding.
  • Alyeska Investment Group first reported a position in Eli Lilly in Q2 2014 and has held it in 22 quarters since.
  • Alyeska Investment Group's Eli Lilly position peaked at $133M in Q1 2017.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.